These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 12231460

  • 21. [Lewy bodies in Parkinson's disease: histological, immunohistochemical, and interferometric examinations].
    Voronkov DN, Salkov VN, Anufriev PL, Khudoerkov RM.
    Arkh Patol; 2018; 80(4):9-13. PubMed ID: 30059066
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Synphilin-1 is present in Lewy bodies in Parkinson's disease.
    Wakabayashi K, Engelender S, Yoshimoto M, Tsuji S, Ross CA, Takahashi H.
    Ann Neurol; 2000 Apr; 47(4):521-3. PubMed ID: 10762166
    [Abstract] [Full Text] [Related]

  • 27. Organization of the human synphilin-1 gene, a candidate for Parkinson's disease.
    Engelender S, Wanner T, Kleiderlein JJ, Wakabayashi K, Tsuji S, Takahashi H, Ashworth R, Margolis RL, Ross CA.
    Mamm Genome; 2000 Sep; 11(9):763-6. PubMed ID: 10967135
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease.
    Shimura H, Schlossmacher MG, Hattori N, Frosch MP, Trockenbacher A, Schneider R, Mizuno Y, Kosik KS, Selkoe DJ.
    Science; 2001 Jul 13; 293(5528):263-9. PubMed ID: 11431533
    [Abstract] [Full Text] [Related]

  • 31. PARK10 candidate RNF11 is expressed by vulnerable neurons and localizes to Lewy bodies in Parkinson disease brain.
    Anderson LR, Betarbet R, Gearing M, Gulcher J, Hicks AA, Stefánsson K, Lah JJ, Levey AI.
    J Neuropathol Exp Neurol; 2007 Oct 13; 66(10):955-64. PubMed ID: 17917589
    [Abstract] [Full Text] [Related]

  • 32. Australian data and meta-analysis lend support for alpha-synuclein (NACP-Rep1) as a risk factor for Parkinson's disease.
    Mellick GD, Maraganore DM, Silburn PA.
    Neurosci Lett; 2005 Feb 28; 375(2):112-6. PubMed ID: 15670652
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Polymorphisms of the alpha-synuclein promoter: expression analyses and association studies in Parkinson's disease.
    Holzmann C, Krüger R, Saecker AM, Schmitt I, Schöls L, Berger K, Riess O.
    J Neural Transm (Vienna); 2003 Jan 28; 110(1):67-76. PubMed ID: 12541013
    [Abstract] [Full Text] [Related]

  • 36. A functional polymorphism in the parkin gene promoter affects the age of onset of Parkinson's disease.
    Sutherland G, Mellick G, Sue C, Chan DK, Rowe D, Silburn P, Halliday G.
    Neurosci Lett; 2007 Mar 06; 414(2):170-3. PubMed ID: 17280783
    [Abstract] [Full Text] [Related]

  • 37. Familial Mutations and Post-translational Modifications of UCH-L1 in Parkinson's Disease and Neurodegenerative Disorders.
    Lee YC, Hsu SD.
    Curr Protein Pept Sci; 2017 Mar 06; 18(7):733-745. PubMed ID: 26899237
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Lewy body pathology is associated with mitochondrial DNA damage in Parkinson's disease.
    Müller SK, Bender A, Laub C, Högen T, Schlaudraff F, Liss B, Klopstock T, Elstner M.
    Neurobiol Aging; 2013 Sep 06; 34(9):2231-3. PubMed ID: 23566333
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.